5 ADA 2026 Diabetes Care Updates You Should Know
Every year, diabetes care gets a little smarter, more personalized, and more focused on what can make everyday life easier for people living with…
Do you have obesity, with or without Type 2 Diabetes?
You may qualify for a research study evaluating an investigational medication for weight management.
This study is designed to understand how well and how safely two doses of CagriSema help people manage their weight when combined with a lower calorie diet and increased physical activity.
Participants will receive a weekly dose of either the study medication or a comparator medication (Semaglutide). Visits include a combination of in-person and phone appointments.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator